deltatrials
Unknown PHASE4 INTERVENTIONAL 2-arm NCT05489016

HuoXin Pills Intervention on Patients With Coronary Heart Disease After Drug-Coated Balloon Implantation (HAPPY-DCB)

Prospective, Randomized, Double-blind, Placebo-controlled Clinical Study of Yuekang Huoxin Pill (Concentrated Pill) Intervening in the Prognosis of Patients With Coronary Heart Disease After Drug-Coated Balloon Implantation With Qi Deficiency and Blood Stasis Syndrome

Sponsor: China National Center for Cardiovascular Diseases

Conditions Coronary Heart Disease Medicine, Chinese Traditional
Interventions Yuekang Huoxin Pills (concentrated pills) Yuekang Huoxin Pills (concentrated pills)simulant
Updated 7 times since 2022 Last updated: Aug 14, 2022 Started: Aug 5, 2022 Primary completion: Jan 1, 2024 Completion: Jul 13, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Coronary Heart Disease and Medicine, Chinese Traditional and is currently ongoing. China National Center for Cardiovascular Diseases leads this study, which shows 7 recorded versions since 2022 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Sep 2022 – ~Feb 2023 · 5 months · monthly snapshotRecruiting~Feb 2023 – ~Sep 2023 · 7 months · monthly snapshotRecruiting~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshotRecruiting~Jan 2025 – ~Aug 2025 · 7 months · monthly snapshotRecruiting~Aug 2025 – present · 11 months · monthly snapshotUnknown

Change History

7 versions recorded

  1. Aug 2025 — Present [monthly]

    Unknown PHASE4

    Status: Recruiting → Unknown

  2. Jan 2025 — Aug 2025 [monthly]

    Recruiting PHASE4

  3. Sep 2024 — Jan 2025 [monthly]

    Recruiting PHASE4

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE4

  5. Sep 2023 — Jul 2024 [monthly]

    Recruiting PHASE4

▶ Show 2 earlier versions

  1. Feb 2023 — Sep 2023 [monthly]

    Recruiting PHASE4

  2. Sep 2022 — Feb 2023 [monthly]

    Recruiting PHASE4

    First recorded

Aug 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • China National Center for Cardiovascular Diseases
  • Chinese Academy of Medical Sciences, Fuwai Hospital
  • Fuwai Yunnan Cardiovascular Hospital
Data source: China National Center for Cardiovascular Diseases

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations